IGLON5 and sleep disorder: In this situation, as well as in cases with TDP-43 proteinopathy “only”, we also recommend establishing the diagnosis in an integrated manner, i.e., in the presence of anti-IgLON5 antibodies in the CSF and the presence of brainstem symptoms including a sleep disorder and/or a supportive HLA genetic background.